[go: up one dir, main page]

CN117304057A - Sea buckthorn oil ceramide and its synthesis method and use - Google Patents

Sea buckthorn oil ceramide and its synthesis method and use Download PDF

Info

Publication number
CN117304057A
CN117304057A CN202310051531.2A CN202310051531A CN117304057A CN 117304057 A CN117304057 A CN 117304057A CN 202310051531 A CN202310051531 A CN 202310051531A CN 117304057 A CN117304057 A CN 117304057A
Authority
CN
China
Prior art keywords
ceramide
sea buckthorn
acid
buckthorn oil
sphingosine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202310051531.2A
Other languages
Chinese (zh)
Inventor
杨超文
叶柳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shenzhen Dikeman Biotechnology Co ltd
Original Assignee
Shenzhen Dikeman Biotechnology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shenzhen Dikeman Biotechnology Co ltd filed Critical Shenzhen Dikeman Biotechnology Co ltd
Priority to CN202310051531.2A priority Critical patent/CN117304057A/en
Priority to EP23893956.5A priority patent/EP4624449A1/en
Priority to PCT/CN2023/133524 priority patent/WO2024109867A1/en
Priority to KR1020257019053A priority patent/KR20250112263A/en
Priority to JP2025529875A priority patent/JP2025536776A/en
Priority to AU2023383894A priority patent/AU2023383894A1/en
Publication of CN117304057A publication Critical patent/CN117304057A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/20Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a carbon atom of an acyclic unsaturated carbon skeleton
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12Fatty acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/164Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/68Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/02Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Botany (AREA)
  • Cosmetics (AREA)

Abstract

本发明属于生物医药技术领域,公开了沙棘油神经酰胺,其由沙棘油脂肪酸与鞘氨醇类化合物反应得到,所述鞘氨醇类化合物选自鞘氨醇、植物鞘氨醇、二氢鞘氨醇,本方案还公开了沙棘油神经酰胺的合成方法与用途。沙棘油神经酰胺在皮肤天然屏障的修复、组织愈合、抗衰老等方面表现出优异性能,在化妆品、保健品、生物医药等领域有着广泛的应用前景。

The invention belongs to the technical field of biomedicine and discloses sea buckthorn oil ceramide, which is obtained by reacting sea buckthorn oil fatty acids with sphingosine compounds. The sphingosine compounds are selected from the group consisting of sphingosine, phytosphingosine, and dihydrosphingosine. Amino alcohol, this plan also discloses the synthesis method and use of sea buckthorn oil ceramide. Sea buckthorn oil ceramide has excellent properties in repairing the skin's natural barrier, tissue healing, and anti-aging, and has broad application prospects in cosmetics, health products, biomedicine and other fields.

Description

沙棘油神经酰胺及其合成方法与用途Sea buckthorn oil ceramide and its synthesis method and use

技术领域Technical field

本发明属于生物医药技术领域,具体涉及沙棘油神经酰胺及其合成方法与用途。The invention belongs to the field of biomedicine technology, and specifically relates to sea buckthorn oil ceramide and its synthesis method and use.

背景技术Background technique

神经酰胺(Ceramide,又称分子钉)天然存在于皮肤中,是皮肤屏障(角质层)非常重要的组成部分,含量高达40~50wt%,神经酰胺是一类由鞘氨醇类长链碱基与脂肪酸组成的神经鞘氨脂质,其中的鞘氨醇部分、脂肪酸部分的碳链长度、不饱和度和羟基数目都是可以变化的,神经酰胺代表了一类化合物。神经酰胺在调控皮肤屏障功能,恢复皮肤水分以及增强皮肤角质细胞之间的粘着力等方面表现出优异的性能。Ceramide (Ceramide, also known as molecular nail) naturally exists in the skin and is a very important component of the skin barrier (stratum corneum). The content is as high as 40-50wt%. Ceramide is a type of long-chain base composed of sphingosine. Sphingosine lipids composed of fatty acids, in which the sphingosine part and the carbon chain length of the fatty acid part, the degree of unsaturation and the number of hydroxyl groups can all be changed, ceramide represents a class of compounds. Ceramides have excellent properties in regulating skin barrier function, restoring skin moisture, and enhancing adhesion between skin keratinocytes.

由于神经酰胺的重要性,许多化妆品和制药公司正在研究、开发相应的产品。天然植物来源的神经酰胺因其更加可持续和更加环保的原料来源,以及与皮肤神经酰胺成分相近的特性,能形成有效的皮肤屏障防止水分流失,并对抗外部损坏,将可能成为下一代环境友好、安全可靠的神经酰胺产品。Due to the importance of ceramides, many cosmetics and pharmaceutical companies are researching and developing corresponding products. Natural plant-derived ceramides are likely to become the next generation of environmentally friendly products due to their more sustainable and environmentally friendly raw material sources and similar properties to skin ceramide components. They can form an effective skin barrier to prevent moisture loss and resist external damage. , safe and reliable ceramide products.

沙棘油由沙棘籽或沙棘果经过超临界萃取或亚临界生物技术低温萃取得到的棕黄色到棕红色透明油状液体,是集沙棘有效成分为一体的高度浓缩物,内含黄酮、有机酸、生物碱、甾醇类、三萜烯类及各种维生素等140多种生物活性成分。沙棘油含有大量不饱和脂肪酸,如亚油酸、油酸、亚麻酸等和少量的饱和脂肪酸,如棕榈酸、硬脂酸、肉豆蔻酸等,被认为是对治疗湿疹十分有效的植物油。另外,它还含有与人体皮脂成分接近的棕榈油烯酸,所以有强化皮肤再生、修复损伤黏膜的作用。沙棘油作为保健食品原料,已在抗氧化、抗疲劳、护肝、降血脂等方面得到广泛运用。沙棘油作为药用原料,具有明显生物作用,其抗感染强、促进愈合快,被广泛用于治疗烧伤、烫伤、冻伤、刀伤等方面。沙棘油对扁桃体炎、口腔炎、结膜炎、角膜炎、妇科宫颈炎等都有良好而稳定的疗效。沙棘油是多种维生素和生物活性物质的复合体,它能滋养皮肤、促进新陈代谢、抗过敏,杀菌消炎,促进上皮细胞再生,对皮肤有修复作用,保持皮肤的酸性环境,具有较强的渗透性,因而也是美容护肤的重要原料。沙棘中的沙棘总黄酮可直接捕获超氧自由基和羟自由基,VE、VC超氧化物歧化酶(SOD)具有抗氧化及消除细胞膜上自由基的作用,有效延缓人体衰老;沙棘中的VC含量居水果、蔬菜之首,被誉为“VC之王”,而VC正是一种天然的体内美白剂,能有效抑制皮肤上异常色素的沉积以及酪氨酸酶的活性,并有助多巴色素(酪氨酸转化成为黑色素的中间体)的还原,从而减少黑色素形成,有效净白皮肤。Sea buckthorn oil is a brown-yellow to brown-red transparent oily liquid obtained from sea buckthorn seeds or sea buckthorn fruits through supercritical extraction or subcritical biotechnology low-temperature extraction. It is a highly concentrated product that integrates the active ingredients of sea buckthorn and contains flavonoids, organic acids, biological More than 140 biologically active ingredients including bases, sterols, triterpenes and various vitamins. Sea buckthorn oil contains a large amount of unsaturated fatty acids, such as linoleic acid, oleic acid, linolenic acid, etc. and a small amount of saturated fatty acids, such as palmitic acid, stearic acid, myristic acid, etc., and is considered to be a very effective vegetable oil in the treatment of eczema. In addition, it also contains palmoleoleic acid, which has a composition similar to human sebum, so it can strengthen skin regeneration and repair damaged mucous membranes. As a health food raw material, sea buckthorn oil has been widely used in antioxidant, anti-fatigue, liver protection, and lowering blood lipids. As a medicinal raw material, sea buckthorn oil has obvious biological effects. It has strong anti-infection and promotes fast healing. It is widely used to treat burns, scalds, frostbite, knife wounds, etc. Sea buckthorn oil has good and stable effects on tonsillitis, stomatitis, conjunctivitis, keratitis, gynecological cervicitis, etc. Sea buckthorn oil is a complex of multiple vitamins and bioactive substances. It can nourish the skin, promote metabolism, resist allergies, sterilize and reduce inflammation, promote epithelial cell regeneration, repair the skin, maintain the acidic environment of the skin, and has strong penetration. Sex, so it is also an important raw material for beauty and skin care. The total flavonoids in seabuckthorn can directly capture superoxide free radicals and hydroxyl free radicals. VE and VC superoxide dismutase (SOD) have antioxidant and eliminate free radicals on cell membranes, effectively delaying human aging; VC in seabuckthorn Its content ranks first among fruits and vegetables, and it is known as the "King of VC". VC is a natural whitening agent in the body, which can effectively inhibit the deposition of abnormal pigments on the skin and the activity of tyrosinase, and help many Reduction of melanin (the intermediate in which tyrosine is converted into melanin), thereby reducing the formation of melanin and effectively whitening the skin.

发明内容Contents of the invention

本发明的目的是提供一种利用植物来源的沙棘油脂肪酸合成得到的神经酰胺。The object of the present invention is to provide a ceramide synthesized from plant-derived sea buckthorn oil fatty acids.

本发明的另一目的是提供沙棘油神经酰胺的合成方法,其利用天然植物来源且易得的沙棘油油脂或者沙棘油脂肪酸作为原料。Another object of the present invention is to provide a method for synthesizing sea buckthorn oil ceramide, which uses natural plant-derived and easily available sea buckthorn oil or sea buckthorn oil fatty acid as raw material.

本发明的另一目的是提供沙棘油神经酰胺的用途。Another object of the present invention is to provide the use of sea buckthorn oil ceramide.

为达到上述目的之一,本发明采用以下技术方案:In order to achieve one of the above objectives, the present invention adopts the following technical solutions:

本发明的第一方面,沙棘油神经酰胺,其由沙棘油脂肪酸与鞘氨醇类化合物反应得到,所述鞘氨醇类化合物选自鞘氨醇、植物鞘氨醇、二氢鞘氨醇。The first aspect of the present invention is sea buckthorn oil ceramide, which is obtained by reacting sea buckthorn oil fatty acids with sphingosine compounds, and the sphingosine compounds are selected from the group consisting of sphingosine, phytosphingosine, and dihydrosphingosine.

反应即可以是化学合成反应(如下文详述),也可采用微生物发酵法,即应用雪氏毕赤酵母或酿酒酵母,在一定环境下发酵得到鞘氨醇类化合物,然后加入脂肪酸,最终得到神经酰胺;或者以沙棘油为原料,选用合适的菌株,进行发酵得到沙棘油神经酰胺。The reaction can be a chemical synthesis reaction (as detailed below) or a microbial fermentation method, that is, using Pichia pastoris or Saccharomyces cerevisiae to ferment under a certain environment to obtain sphingosine compounds, and then adding fatty acids to finally obtain Ceramide; or use sea buckthorn oil as raw material, select a suitable strain, and ferment it to obtain sea buckthorn oil ceramide.

鞘氨醇指2-氨基-4-十八烯-1,3-二醇,植物鞘氨醇指2-氨基-十八烷-1,3,4-三醇,二氢鞘氨醇指2-氨基-十八烷-1,3-二醇。Sphingosine refers to 2-amino-4-octadecene-1,3-diol, phytosphingosine refers to 2-amino-octadecane-1,3,4-triol, and dihydrosphingosine refers to 2 -Amino-octadecane-1,3-diol.

进一步地,所述沙棘油脂肪酸由沙棘籽油或沙棘果油水解得到。Further, the sea buckthorn oil fatty acid is obtained by hydrolyzing sea buckthorn seed oil or sea buckthorn fruit oil.

进一步地,所述沙棘油脂肪酸含有20~35wt%油酸。Further, the sea buckthorn oil fatty acid contains 20-35wt% oleic acid.

进一步地,所述沙棘油脂肪酸含有8~30wt%棕榈酸。Further, the sea buckthorn oil fatty acid contains 8 to 30 wt% palmitic acid.

进一步地,所述沙棘油脂肪酸含有4~40wt%亚油酸。Further, the sea buckthorn oil fatty acid contains 4 to 40 wt% linoleic acid.

进一步地,所述沙棘油脂肪酸含有2~30wt%亚麻酸。Further, the sea buckthorn oil fatty acid contains 2 to 30 wt% linolenic acid.

进一步地,所述沙棘油脂肪酸含有0.5~35wt%棕榈一烯酸。Further, the sea buckthorn oil fatty acid contains 0.5 to 35 wt% palmitic acid.

进一步地,所述沙棘油脂肪酸含有0.5~3wt%硬脂酸。Further, the sea buckthorn oil fatty acid contains 0.5-3wt% stearic acid.

此外,沙棘油脂肪酸还含有0~1wt%肉豆蔻酸。In addition, sea buckthorn oil fatty acid also contains 0 to 1 wt% myristic acid.

沙棘油脂肪酸的组成为:20~35wt%油酸、8~30wt%棕榈酸、4~40wt%亚油酸、2~30wt%亚麻酸、0.5~35wt%棕榈一烯酸、0.5~3wt%硬脂酸、0~1wt%肉豆蔻酸。The fatty acid composition of sea buckthorn oil is: 20~35wt% oleic acid, 8~30wt% palmitic acid, 4~40wt% linoleic acid, 2~30wt% linolenic acid, 0.5~35wt% palmitic acid, 0.5~3wt% hard Fatty acid, 0~1wt% myristic acid.

沙棘油脂肪酸的主要成分为油酸,其他的脂肪酸包括棕榈酸、亚油酸、亚麻酸、棕榈一烯酸、硬脂酸,这些是必要组分,受植物品种、土壤、气候、产地、采摘季节、提取过程的影响,各组分的含量会有所不同,而肉豆蔻酸不一定含有,是可选组分或者非必要组分。The main fatty acid component of sea buckthorn oil is oleic acid. Other fatty acids include palmitic acid, linoleic acid, linolenic acid, palmitic acid, and stearic acid. These are essential components and are affected by plant species, soil, climate, origin, and picking. The content of each component will be different due to the influence of season and extraction process. However, myristic acid may not be included and is an optional or non-essential component.

沙棘油神经酰胺,其组成包括:油酸神经酰胺,棕榈酸神经酰胺,亚油酸神经酰胺,亚麻酸神经酰胺,棕榈一烯酸神经酰胺,硬脂酸神经酰胺;因为脂肪酸都会参与相同的反应,反应后神经酰胺的质量占比变化不大,所以与沙棘油脂肪酸的组成类似,沙棘油神经酰胺的组成为:20~35wt%油酸神经酰胺,8~30wt%棕榈酸神经酰胺,4~40wt%亚油酸神经酰胺,2~30wt%亚麻酸神经酰胺,0.5~35wt%棕榈一烯酸神经酰胺,0.5~3wt%硬脂酸神经酰胺。各组分的含量因沙棘油脂肪酸或油脂中各脂肪酸的含量不同而存在差异。此外,沙棘油神经酰胺还包括肉豆蔻酸与鞘氨醇类化合物反应得到的神经酰胺,即还包括0~1wt%肉豆蔻酸神经酰胺。沙棘油神经酰胺还包括黄酮、生物碱、甾醇类、三萜烯类、维生素等存在于沙棘油脂肪酸中但是不与鞘氨醇类化合物反应的化合物。Sea buckthorn oil ceramide, its composition includes: oleic acid ceramide, palmitic acid ceramide, linoleic acid ceramide, linolenic acid ceramide, palmitic acid ceramide, stearic acid ceramide; because fatty acids all participate in the same reaction , the mass proportion of ceramide does not change much after the reaction, so it is similar to the composition of sea buckthorn oil fatty acids. The composition of sea buckthorn oil ceramide is: 20~35wt% oleic acid ceramide, 8~30wt% palmitic acid ceramide, 4~ 40wt% linoleic acid ceramide, 2-30wt% linolenic acid ceramide, 0.5-35wt% palmitic acid ceramide, 0.5-3wt% stearic acid ceramide. The content of each component varies depending on the content of fatty acids in sea buckthorn oil or oil. In addition, sea buckthorn oil ceramide also includes ceramide obtained by reacting myristic acid and sphingosine compounds, that is, it also includes 0 to 1 wt% myristic acid ceramide. Sea buckthorn oil ceramides also include flavonoids, alkaloids, sterols, triterpenes, vitamins and other compounds that are present in the fatty acids of sea buckthorn oil but do not react with sphingosine compounds.

沙棘油神经酰胺,其组成包括:油酸神经酰胺,棕榈酸神经酰胺,亚油酸神经酰胺,亚麻酸神经酰胺;油酸神经酰胺占比20~35wt%,棕榈酸神经酰胺占比8~30wt%,亚油酸神经酰胺占比4~40wt%,亚麻酸神经酰胺2~30wt%。Sea buckthorn oil ceramide, its composition includes: oleic acid ceramide, palmitic acid ceramide, linoleic acid ceramide, linolenic acid ceramide; oleic acid ceramide accounts for 20 to 35wt%, and palmitic acid ceramide accounts for 8 to 30wt %, linoleic acid ceramide accounts for 4 to 40 wt%, and linolenic acid ceramide accounts for 2 to 30 wt%.

进一步地,沙棘油神经酰胺包括棕榈一烯酸神经酰胺,棕榈一烯酸神经酰胺占比0.5~35wt%。Further, the sea buckthorn oil ceramide includes palmitic acid ceramide, and the palmitic acid ceramide accounts for 0.5 to 35wt%.

进一步地,沙棘油神经酰胺包括硬脂酸神经酰胺,硬脂酸神经酰胺占比0.5~3wt%。Further, the sea buckthorn oil ceramide includes stearic acid ceramide, and stearic acid ceramide accounts for 0.5 to 3 wt%.

进一步地,沙棘油神经酰胺包括不超过1wt%的肉豆蔻酸神经酰胺,尤其是0.1~1wt%肉豆蔻酸神经酰胺。Further, the sea buckthorn oil ceramide includes no more than 1 wt% myristate ceramide, especially 0.1 to 1 wt% myristate ceramide.

油酸神经酰胺是油酸与鞘氨醇类化合物缩合反应得到,包括油酸植物鞘氨醇神经酰胺、油酸鞘氨醇神经酰胺、油酸二氢鞘氨醇神经酰胺;棕榈酸神经酰胺是棕榈酸与鞘氨醇类化合物缩合反应得到,包括棕榈酸植物鞘氨醇神经酰胺、棕榈酸鞘氨醇神经酰胺、棕榈酸二氢鞘氨醇神经酰胺;亚油酸神经酰胺是亚油酸与鞘氨醇类化合物缩合反应得到,包括亚油酸植物鞘氨醇神经酰胺、亚油酸鞘氨醇神经酰胺、亚油酸二氢鞘氨醇神经酰胺;亚麻酸神经酰胺是亚麻酸与鞘氨醇类化合物缩合反应得到,包括亚麻酸植物鞘氨醇神经酰胺、亚麻酸鞘氨醇神经酰胺、亚麻酸二氢鞘氨醇神经酰胺;硬脂酸神经酰胺是硬脂酸与鞘氨醇类化合物缩合反应得到,包括硬脂酸植物鞘氨醇神经酰胺、硬脂酸鞘氨醇神经酰胺、硬脂酸二氢鞘氨醇神经酰胺;棕榈一烯酸神经酰胺、肉豆蔻酸神经酰胺等以此类推。Oleic acid ceramide is obtained by the condensation reaction of oleic acid and sphingosine compounds, including oleic acid phytosphingosine ceramide, oleic acid sphingosine ceramide, oleic acid dihydrosphingosine ceramide; palmitic acid ceramide is It is obtained by the condensation reaction of palmitic acid and sphingosine compounds, including palmitic acid phytosphingosine ceramide, palmitic acid sphingosine ceramide, palmitic dihydrosphingosine ceramide; linoleic acid ceramide is obtained from linoleic acid and sphingosine ceramide. Obtained from the condensation reaction of sphingosine compounds, including linoleic acid phytosphingosine ceramide, linoleic acid sphingosine ceramide, linoleic acid dihydrosphingosine ceramide; linolenic acid ceramide is a combination of linolenic acid and sphingosine Obtained from the condensation reaction of alcohol compounds, including linolenic acid phytosphingosine ceramide, linolenic acid sphingosine ceramide, linolenic acid dihydrosphingosine ceramide; stearic acid ceramide is a compound of stearic acid and sphingosine Obtained by condensation reaction, including stearic acid phytosphingosine ceramide, stearic acid sphingosine ceramide, stearic dihydrosphingosine ceramide; palmitic acid ceramide, myristic acid ceramide, etc. analogy.

本发明的第二方面,沙棘油神经酰胺的合成方法,包括以下步骤:The second aspect of the present invention, the synthesis method of sea buckthorn oil ceramide, includes the following steps:

在缩合剂、有机碱条件下,沙棘油脂肪酸与鞘氨醇类化合物反应,所述缩合剂为EDCI,所述有机碱为Et3N。Sea buckthorn oil fatty acids react with sphingosine compounds under the conditions of a condensing agent and an organic base. The condensing agent is EDCI and the organic base is Et 3 N.

进一步地,所述沙棘油脂肪酸、鞘氨醇类化合物、EDCI、Et3N的摩尔比为1:(1~1.5):(1~2):(1~2),所述反应的溶剂为二氯甲烷、四氢呋喃、乙酸乙酯、乙腈中的至少一种。Further, the molar ratio of the sea buckthorn oil fatty acid, sphingosine compounds, EDCI, and Et 3 N is 1: (1~1.5): (1~2): (1~2), and the solvent of the reaction is At least one of methylene chloride, tetrahydrofuran, ethyl acetate, and acetonitrile.

在市场上购买的沙棘油一般是油脂形态,需要水解成沙棘油脂肪酸,因此还包括以下步骤:Seabuckthorn oil purchased on the market is generally in the form of oil and needs to be hydrolyzed into seabuckthorn oil fatty acids, so the following steps are also included:

沙棘油油脂通过皂化反应水解得到沙棘油脂肪酸。Sea buckthorn oil and fat are hydrolyzed through saponification reaction to obtain sea buckthorn oil fatty acids.

进一步地,所述皂化反应是沙棘油油脂在氢氧化钾溶液中水解。Further, the saponification reaction is hydrolysis of sea buckthorn oil in a potassium hydroxide solution.

进一步地,所述沙棘油油脂与氢氧化钾的质量比为1:(1~2)。Further, the mass ratio of the sea buckthorn oil and potassium hydroxide is 1: (1-2).

本发明的第三方面,沙棘油神经酰胺在化妆品、药品、膳食品或保健品中的用途。The third aspect of the present invention is the use of sea buckthorn oil ceramide in cosmetics, medicines, dietary products or health care products.

进一步地,所述沙棘油神经酰胺具有皮肤屏障修复、组织愈合、抗衰老、抗光老化、抗氧化、促进胶原合成、维持弹性蛋白活力、美白功效中的至少一种。Furthermore, the sea buckthorn oil ceramide has at least one of the effects of skin barrier repair, tissue healing, anti-aging, anti-photoaging, anti-oxidation, promoting collagen synthesis, maintaining elastin vitality, and whitening.

一种组合物,包括沙棘油神经酰胺,所述组合物具有皮肤屏障修复、组织愈合、抗衰老、抗光老化、抗氧化、促进胶原合成、维持弹性蛋白活力、美白功效中的至少一种。A composition, including sea buckthorn oil ceramide, has at least one of the effects of skin barrier repair, tissue healing, anti-aging, anti-photoaging, anti-oxidation, promoting collagen synthesis, maintaining elastin vitality, and whitening.

该组合物含有可接受的辅料,包括增溶剂、防腐剂、抗氧剂、pH调节剂、促渗剂、脂质体、保湿剂、增稠剂、螯合剂、肤感调节剂、表面活性剂、乳化剂、香精及色素中的一种或多种;该组合物为霜剂、乳剂、溶液剂、膜剂、气雾或喷雾形式。The composition contains acceptable excipients, including solubilizers, preservatives, antioxidants, pH adjusters, penetration enhancers, liposomes, moisturizers, thickeners, chelating agents, skin texture modifiers, and surfactants. , emulsifier, flavor and pigment; the composition is in the form of cream, emulsion, solution, film, aerosol or spray.

本发明具有以下有益效果:The invention has the following beneficial effects:

沙棘油脂肪酸属于天然形成的脂肪酸,最主要的成分是油酸、棕榈酸和亚油酸,此外还含有亚麻酸、棕榈一烯酸、硬脂酸等,其与天然存在于皮肤中的鞘氨醇类化合物,经温和反应制备而得的沙棘油神经酰胺,在皮肤天然屏障的修复、抗氧化、抗衰老等方面表现出优异性能,在化妆品、保健品、生物医药等领域有着广泛的应用前景。Sea buckthorn oil fatty acids are naturally occurring fatty acids. The main components are oleic acid, palmitic acid and linoleic acid. In addition, they also contain linolenic acid, palmitic acid, stearic acid, etc., which are closely related to sphingosine naturally present in the skin. Alcohol compounds, sea buckthorn oil ceramide prepared through mild reaction, show excellent performance in the repair of skin's natural barrier, antioxidant, anti-aging, etc., and have broad application prospects in cosmetics, health products, biomedicine and other fields. .

1、与单一的神经酰胺相比效果更好。不同的神经酰胺,因其结构的差异,功效也会存在差异,单一结构的神经酰胺一般难以具备全面的效果。本方案基于仿生的思路,利用天然来源的沙棘油油脂或脂肪酸作为原料,合成复合的神经酰胺,以弥补不同神经酰胺功效的差异,沙棘油中的微量脂肪酸可以形成微量神经酰胺,起到功效补充的作用。1. Better effect than single ceramide. Different ceramides have different effects due to their structural differences. Ceramides with a single structure are generally difficult to have a comprehensive effect. This solution is based on the idea of bionics. It uses sea buckthorn oil or fatty acids from natural sources as raw materials to synthesize complex ceramides to make up for the differences in the efficacy of different ceramides. The trace fatty acids in sea buckthorn oil can form trace amounts of ceramides to supplement the efficacy. role.

2、与复配的神经酰胺相比效果更好。除了脂肪酸,沙棘油中还含有黄酮、有机酸、生物碱、甾醇类、三萜烯类及各种维生素等140多种生物活性成分,这些营养物质有滋润皮肤、增强细胞活力等效果,用沙棘油合成的神经酰胺,与沙棘油中含有的其它活性成分具有协同增效的作用,相比按照类似比例复配的神经酰胺,具有更好的效果。2. It has better effect than compound ceramide. In addition to fatty acids, sea buckthorn oil also contains more than 140 biologically active ingredients such as flavonoids, organic acids, alkaloids, sterols, triterpenes and various vitamins. These nutrients have the effects of moisturizing the skin and enhancing cell vitality. Ceramides synthesized from oil have a synergistic effect with other active ingredients contained in sea buckthorn oil, and have better effects than ceramides compounded in similar proportions.

3、成本更低。本发明的方法快速得到多种神经酰胺复配的组合物,植物源的沙棘油油脂或其脂肪酸来源广泛、易于商业化获取、成本较低,更加环保经济,有别于将不同的单一神经酰胺混合复配的思路,单一成分的脂肪酸不仅原料价格高,而且需要分别生产不同的神经酰胺,然后再进行复配,增加了制备成本。3. Lower cost. The method of the present invention quickly obtains a composite composition of multiple ceramides. Plant-derived sea buckthorn oil or its fatty acids have a wide range of sources, are easy to obtain commercially, have lower costs, are more environmentally friendly and economical, and are different from combining different single ceramides. According to the idea of mixing and compounding, single-component fatty acids not only have high raw material prices, but also need to produce different ceramides separately and then compound them, which increases the preparation cost.

4、合成方法简单。本发明的方法可以采用化学合成,实现一步制备多种神经酰胺,也可以使用微生物发酵法。4. The synthesis method is simple. The method of the present invention can adopt chemical synthesis to prepare multiple ceramides in one step, or can also use microbial fermentation.

附图说明Description of the drawings

图1为实施例4细胞迁移能力测试结果;Figure 1 is the test result of cell migration ability in Example 4;

图2、3为实施例5弹性蛋白酶抑制率柱形图;Figures 2 and 3 are bar graphs of the elastase inhibition rate in Example 5;

图4、5为实施例6抗光老化测试MMP1表达量柱形图;Figures 4 and 5 are bar graphs of MMP1 expression in the photoaging resistance test of Example 6;

图6、7为实施例7抗氧化性测试DPPH自由基清除率柱形图;Figures 6 and 7 are bar graphs of DPPH free radical scavenging rate in the antioxidant test of Example 7;

图8为实施例8美白活性测试黑色素含量柱形图。Figure 8 is a bar graph of melanin content in the whitening activity test of Example 8.

具体实施方式Detailed ways

下面结合具体实施例对本发明做进一步的说明。The present invention will be further described below in conjunction with specific embodiments.

EDCI指1-乙基-(3-二甲基氨基丙基)碳二亚胺,Et3N指三乙胺。硅胶柱层析使用青岛海洋硅胶(粒径0.040-0.063mm)。薄层色谱分析(TLC)使用60F254硅胶板,TLC显色采用UV光(254nm)或碘。EDCI refers to 1-ethyl-(3-dimethylaminopropyl)carbodiimide, and Et 3 N refers to triethylamine. Silica gel column chromatography uses Qingdao marine silica gel (particle size 0.040-0.063mm). Thin layer chromatography (TLC) uses 60F254 silica gel plate, and TLC color development uses UV light (254nm) or iodine.

实施例1Example 1

沙棘油脂肪酸和植物鞘氨醇合成神经酰胺Sea buckthorn oil fatty acid and phytosphingosine synthesize ceramide

第一步:将50g沙棘籽油油脂溶于60mL四氢呋喃,冰浴下冷却,滴加100mL氢氧化钾(25wt%)溶液,滴加完毕后升至室温反应,至TLC检测反应完毕。Step 1: Dissolve 50g of sea buckthorn seed oil in 60mL of tetrahydrofuran, cool it in an ice bath, add dropwise 100mL of potassium hydroxide (25wt%) solution, and after completion of the dropwise addition, rise to room temperature for reaction until TLC detects that the reaction is complete.

后处理:加入稀盐酸(3N)调节反应体系的pH值到3,加入150mL乙酸乙酯萃取水相,加入100mL饱和食盐水洗一次,有机相加入无水Na2SO4干燥,过滤并真空浓缩,得到39.6g沙棘油脂肪酸。Post-processing: Add dilute hydrochloric acid (3N) to adjust the pH value of the reaction system to 3, add 150 mL ethyl acetate to extract the aqueous phase, add 100 mL saturated brine and wash once, add anhydrous Na 2 SO 4 to the organic phase to dry, filter and concentrate in vacuum. 39.6g of sea buckthorn oil fatty acids were obtained.

第二步:将沙棘油脂肪酸(50mmol,以主成分脂肪酸计)、EDCI(60mmol)、Et3N(60mmol)加入250mL圆底烧瓶中,再加入100mL二氯甲烷,随后在室温条件下搅拌1小时,随后将植物鞘氨醇(60mmol)加入到反应体系中,在室温条件下搅拌,至TLC检测反应完毕。Step 2: Add sea buckthorn oil fatty acid (50mmol, calculated as the main component fatty acid), EDCI (60mmol), and Et 3 N (60mmol) into a 250mL round-bottomed flask, then add 100mL dichloromethane, and then stir at room temperature for 1 hours, then phytosphingosine (60 mmol) was added to the reaction system, and stirred at room temperature until the reaction was completed as detected by TLC.

后处理:加入水淬灭反应,分离有机层,干燥,过滤并真空浓缩后经溶剂洗涤得到沙棘油神经酰胺,产物经HPLC分析,HPLC色谱条件:使用岛津高效液相色谱仪(LC-2030C3DPlus),用Innoval ODS-2 4.6*250mm,5μm色谱柱,柱温:30℃,进样体积:10μL,流速:1.0mL/min,蒸发温度:40℃,载气流速:2.5L/min,流动相:100%甲醇。Post-processing: add water to quench the reaction, separate the organic layer, dry, filter and concentrate in vacuum, then wash with solvent to obtain sea buckthorn oil ceramide. The product is analyzed by HPLC. HPLC chromatography conditions: use Shimadzu high-performance liquid chromatography (LC-2030C3DPlus) ), using Innoval ODS-2 4.6*250mm, 5μm column, column temperature: 30℃, injection volume: 10μL, flow rate: 1.0mL/min, evaporation temperature: 40℃, carrier gas flow rate: 2.5L/min, flowing Phase: 100% methanol.

各成分HPLC的保留时间为:棕榈一烯酸-植物鞘氨醇神经酰胺8.1min,亚麻酸-植物鞘氨醇神经酰胺8.6min,亚油酸-植物鞘氨醇神经酰胺9.5min,棕榈酸-植物鞘氨醇神经酰胺10.7min,油酸-植物鞘氨醇神经酰胺11.3min,硬脂酸-植物鞘氨醇神经酰胺13.9min。The HPLC retention times of each component are: palmitic acid-phytosphingosine ceramide 8.1 min, linolenic acid-phytosphingosine ceramide 8.6 min, linoleic acid-phytosphingosine ceramide 9.5 min, palmitic acid- Phytosphingosine ceramide 10.7 minutes, oleic acid-phytosphingosine ceramide 11.3 minutes, stearic acid-phytosphingosine ceramide 13.9 minutes.

所得产物经高效液相色谱分析,油酸-植物鞘氨醇神经酰胺、棕榈酸-植物鞘氨醇神经酰胺、亚油酸-植物鞘氨醇神经酰胺、亚麻酸-植物鞘氨醇神经酰胺、棕榈一烯酸-植物鞘氨醇神经酰胺、硬脂酸-植物鞘氨醇神经酰胺的含量依次为31%、22%、14%、17%、11%、2%,其余为其他成分,含量较少。The obtained products were analyzed by high performance liquid chromatography and found that oleic acid-phytosphingosine ceramide, palmitic acid-phytosphingosine ceramide, linoleic acid-phytosphingosine ceramide, linolenic acid-phytosphingosine ceramide, The contents of palmitic acid-phytosphingosine ceramide and stearic acid-phytosphingosine ceramide are 31%, 22%, 14%, 17%, 11% and 2% respectively, and the rest are other ingredients. less.

实施例2Example 2

沙棘油脂肪酸和鞘氨醇合成神经酰胺Sea buckthorn oil fatty acids and sphingosine synthesize ceramide

第一步:将50g沙棘果油油脂溶于60mL四氢呋喃,冰浴下冷却,滴加100mL氢氧化钾(25wt%)溶液,滴加完毕后升至室温反应,至TLC检测反应完毕。Step 1: Dissolve 50g of sea buckthorn fruit oil in 60mL of tetrahydrofuran, cool it in an ice bath, add dropwise 100mL of potassium hydroxide (25wt%) solution, and after completion of the dropwise addition, rise to room temperature for reaction until TLC detects that the reaction is complete.

后处理:加入稀盐酸(3N)调节反应体系的pH值到3,加入150mL乙酸乙酯萃取水相,加入100mL饱和食盐水洗一次,有机相加入无水Na2SO4干燥,过滤并真空浓缩,得到39.6g沙棘油脂肪酸。Post-processing: Add dilute hydrochloric acid (3N) to adjust the pH value of the reaction system to 3, add 150 mL ethyl acetate to extract the aqueous phase, add 100 mL saturated brine and wash once, add anhydrous Na 2 SO 4 to the organic phase to dry, filter and concentrate in vacuum. 39.6g of sea buckthorn oil fatty acids were obtained.

第二步:将沙棘油脂肪酸(50mmol,以主成分脂肪酸计)、EDCI(65mmol)、Et3N(65mmol)加入250mL圆底烧瓶中,再加入100mL二氯甲烷,随后在室温条件下搅拌1小时,随后将鞘氨醇(55mmol)加入到反应体系中,在室温条件下搅拌,至TLC检测反应完毕。Step 2: Add sea buckthorn oil fatty acid (50mmol, based on the main component fatty acid), EDCI (65mmol), and Et 3 N (65mmol) into a 250mL round-bottomed flask, then add 100mL dichloromethane, and then stir at room temperature for 1 hours, then sphingosine (55 mmol) was added to the reaction system, and stirred at room temperature until the reaction was completed as detected by TLC.

后处理:加入水淬灭反应,分离有机层,干燥,过滤并真空浓缩后经溶剂洗涤得到沙棘油神经酰胺,产物经HPLC分析,HPLC色谱条件:使用岛津高效液相色谱仪(LC-2030C3DPlus),用Innoval ODS-2 4.6*250mm,5μm色谱柱,柱温:30℃,进样体积:10μL,流速:1.0mL/min,蒸发温度:40℃,载气流速:2.5L/min,流动相:100%甲醇。Post-processing: add water to quench the reaction, separate the organic layer, dry, filter and concentrate in vacuum, then wash with solvent to obtain sea buckthorn oil ceramide. The product is analyzed by HPLC. HPLC chromatography conditions: use Shimadzu high-performance liquid chromatography (LC-2030C3DPlus) ), using Innoval ODS-2 4.6*250mm, 5μm column, column temperature: 30℃, injection volume: 10μL, flow rate: 1.0mL/min, evaporation temperature: 40℃, carrier gas flow rate: 2.5L/min, flowing Phase: 100% methanol.

各成分HPLC的保留时间为:亚麻酸-鞘氨醇神经酰胺7.8min,棕榈一烯酸-鞘氨醇神经酰胺8.1min,肉豆蔻酸-鞘氨醇神经酰胺8.3min,亚油酸-鞘氨醇神经酰胺8.7min,油酸-鞘氨醇神经酰胺10.1min,棕榈酸-鞘氨醇神经酰胺10.5min,硬脂酸-鞘氨醇神经酰胺13.5min。The HPLC retention times of each component are: linolenic acid-sphingosine ceramide 7.8 min, palmitic acid-sphingosine ceramide 8.1 min, myristic acid-sphingosine ceramide 8.3 min, linoleic acid-sphingosine ceramide Alcohol ceramide 8.7 minutes, oleic acid-sphingosine ceramide 10.1 minutes, palmitic acid-sphingosine ceramide 10.5 minutes, stearic acid-sphingosine ceramide 13.5 minutes.

所得产物经高效液相色谱分析,油酸-鞘氨醇神经酰胺、棕榈酸-鞘氨醇神经酰胺、亚油酸-鞘氨醇神经酰胺、亚麻酸-鞘氨醇神经酰胺、棕榈一烯酸-鞘氨醇神经酰胺、硬脂酸-鞘氨醇神经酰胺、豆蔻酸-鞘氨醇神经酰胺的含量依次为22%、13%、35%、6%、16%、3%、1%,其余为其他成分,含量较少。The obtained product was analyzed by high performance liquid chromatography, and it was found that oleic acid-sphingosine ceramide, palmitic acid-sphingosine ceramide, linoleic acid-sphingosine ceramide, linolenic acid-sphingosine ceramide, palmitic acid The contents of -sphingosine ceramide, stearic acid-sphingosine ceramide, and myristic acid-sphingosine ceramide are 22%, 13%, 35%, 6%, 16%, 3%, and 1%, respectively. The rest are other ingredients in smaller amounts.

实施例3Example 3

沙棘油脂肪酸和二氢鞘氨醇合成神经酰胺Sea buckthorn oil fatty acid and dihydrosphingosine synthesize ceramide

第一步:将50g沙棘籽油油脂溶于60mL四氢呋喃,冰浴下冷却,滴加100mL氢氧化钾(25wt%)溶液,滴加完毕后升至室温反应,至TLC检测反应完毕。Step 1: Dissolve 50g of sea buckthorn seed oil in 60mL of tetrahydrofuran, cool it in an ice bath, add dropwise 100mL of potassium hydroxide (25wt%) solution, and after completion of the dropwise addition, rise to room temperature for reaction until TLC detects that the reaction is complete.

后处理:加入稀盐酸(3N)调节反应体系的pH值到3,加入150mL乙酸乙酯萃取水相,加入100mL饱和食盐水洗一次,有机相加入无水Na2SO4干燥,过滤并真空浓缩,得到39.6g沙棘油脂肪酸。Post-processing: Add dilute hydrochloric acid (3N) to adjust the pH value of the reaction system to 3, add 150 mL ethyl acetate to extract the aqueous phase, add 100 mL saturated brine and wash once, add anhydrous Na 2 SO 4 to the organic phase to dry, filter and concentrate in vacuum. 39.6g of sea buckthorn oil fatty acids were obtained.

第二步:将沙棘油脂肪酸(50mmol,以主成分脂肪酸计)、EDCI(80mmol)、Et3N(80mmol)加入250mL圆底烧瓶中,再加入100mL二氯甲烷,随后在室温条件下搅拌1小时,随后将二氢鞘氨醇(60mmol)加入到反应体系中,在室温条件下搅拌,至TLC检测反应完毕。Step 2: Add sea buckthorn oil fatty acid (50mmol, based on the main component fatty acid), EDCI (80mmol), and Et 3 N (80mmol) into a 250mL round-bottomed flask, then add 100mL dichloromethane, and then stir at room temperature for 1 hour, then dihydrosphingosine (60 mmol) was added to the reaction system, and stirred at room temperature until the reaction was completed as detected by TLC.

后处理:加入水淬灭反应,分离有机层,干燥,过滤并真空浓缩后经溶剂洗涤得到沙棘油神经酰胺,产物经HPLC分析,HPLC色谱条件:使用岛津高效液相色谱仪(LC-2030C3DPlus),用Innoval ODS-2 4.6*250mm,5μm色谱柱,柱温:30℃,进样体积:10μL,流速:1.0mL/min,蒸发温度:40℃,载气流速:2.5L/min,流动相:100%甲醇。Post-processing: add water to quench the reaction, separate the organic layer, dry, filter and concentrate in vacuum, then wash with solvent to obtain sea buckthorn oil ceramide. The product is analyzed by HPLC. HPLC chromatography conditions: use Shimadzu high-performance liquid chromatography (LC-2030C3DPlus) ), using Innoval ODS-2 4.6*250mm, 5μm column, column temperature: 30℃, injection volume: 10μL, flow rate: 1.0mL/min, evaporation temperature: 40℃, carrier gas flow rate: 2.5L/min, flowing Phase: 100% methanol.

各成分HPLC的保留时间为:亚麻酸-二氢鞘氨醇神经酰胺8.3min,棕榈一烯酸-二氢鞘氨醇神经酰胺9.0min,亚油酸-二氢鞘氨醇神经酰胺9.6min,棕榈酸-二氢鞘氨醇神经酰胺10.6min,油酸-二氢鞘氨醇神经酰胺11.1min,硬脂酸-二氢鞘氨醇神经酰胺13.6min。The HPLC retention times of each component are: linolenic acid-sphingosine ceramide 8.3 min, palmitic acid-sphingosine ceramide 9.0 min, linoleic acid-sphingosine ceramide 9.6 min, Palmitic acid-sphingosine ceramide 10.6 minutes, oleic acid-sphingosine ceramide 11.1 minutes, stearic acid-sphingosine ceramide 13.6 minutes.

所得产物经高效液相色谱分析,油酸-二氢鞘氨醇神经酰胺、棕榈酸-二氢鞘氨醇神经酰胺、亚油酸-二氢鞘氨醇神经酰胺、亚麻酸-二氢鞘氨醇神经酰胺、棕榈一烯酸-二氢鞘氨醇神经酰胺、硬脂酸-二氢鞘氨醇神经酰胺的含量依次为28%、27%、6%、25%、7%、1%,其余为其他成分,含量较少。The obtained products were analyzed by high performance liquid chromatography and found that oleic acid-sphingosine ceramide, palmitic acid-sphingosine ceramide, linoleic acid-sphingosine ceramide, and linolenic acid-sphingosine ceramide The contents of alcohol ceramide, palmitic acid-sphingosine ceramide, and stearic acid-sphingosine ceramide are 28%, 27%, 6%, 25%, 7%, and 1%, respectively. The rest are other ingredients in smaller amounts.

实施例4Example 4

细胞迁移评估皮肤屏障修复作用Cell migration to assess skin barrier repair

原理:当细胞长到融合成单层状态时,在融合的单层细胞上划痕工具制造一个空白区域,空白区域的细胞被机械力去除掉了,通过一段时间的培养,观察细胞向无细胞区域迁移的情况,通过测量细胞的迁移距离反映细胞的迁移能力。Principle: When the cells grow to fuse into a single layer, a scratch tool is used to create a blank area on the fused single layer of cells. The cells in the blank area are removed by mechanical force. After a period of culture, the cells are observed to become cell-free. Regional migration reflects the migration ability of cells by measuring the migration distance of cells.

操作步骤:Steps:

1、培养板划线。首先使用Marker笔在6孔板背后,用直尺比着,均匀的划横线,大约每隔0.5~1cm一道,横穿过孔,每孔至少穿过5条线,划线时注意线不要太粗。1. Line the culture plate. First, use a Marker pen on the back of the 6-well plate, use a ruler to compare, and draw horizontal lines evenly, about every 0.5 to 1cm, across the holes. Each hole should pass through at least 5 lines. When drawing, be careful not to draw lines. Too thick.

2、铺细胞。在孔中加入约5×105个细胞(不同的细胞数量有所不同,根据细胞的生长快慢调整),接种原则为过夜后融合率达到100%。2. Spread the cells. Add about 5 × 10 5 cells into the well (the number of cells varies, and is adjusted according to the growth rate of the cells). The seeding principle is to reach 100% confluence rate after overnight.

3、细胞划线。第二天用枪头,垂直于细胞平面,沿着第一天划在平板背面的线在细胞层上进行划痕(不同孔之间最好使用同一只枪头)。3. Cell line drawing. On the second day, use a pipette tip perpendicular to the cell plane to scratch the cell layer along the line drawn on the back of the plate on the first day (it is best to use the same pipette tip between different wells).

4、洗细胞。划痕完成后,使用无菌PBS洗细胞3次,洗去不贴壁的细胞,即划线时划线的细胞,划线后留下的间隙清晰可见,然后更换新鲜无血清培养基。4. Wash the cells. After scratching is completed, wash the cells 3 times with sterile PBS to remove non-adherent cells, that is, cells that were crossed during scratching. The gap left after scratching is clearly visible, and then replace with fresh serum-free medium.

5、细胞培养、观察。样品(实施例1产物、神经酰胺3B)用培养基稀释后(实施例1产物浓度为100mg/L,神经酰胺3B浓度为100mg/L)加入细胞培养皿,将细胞放入37℃、5wt%CO2培养箱培养,在24h后取出细胞,显微镜观察并测量划痕的宽度,并拍照,用Image J软件计算愈合率。5. Cell culture and observation. After the sample (Example 1 product, Ceramide 3B) is diluted with culture medium (Example 1 product concentration is 100 mg/L, Ceramide 3B concentration is 100 mg/L), add it to the cell culture dish, and place the cells in 37°C, 5wt% Incubate in a CO 2 incubator, take out the cells after 24 hours, observe with a microscope, measure the width of the scratch, and take photos, and use Image J software to calculate the healing rate.

结果如图1所示,相比溶剂对照组,实验组的划痕宽度更窄,说明沙棘油神经酰胺具有更好的组织愈合能力。溶剂对照组在24h后的愈合率为21.35%,沙棘油神经酰胺在24h后的愈合率为59.48%。本发明的化合物明显提升了细胞愈合速率,具备良好的皮肤组织修复活性。The results are shown in Figure 1. Compared with the solvent control group, the scratch width of the experimental group was narrower, indicating that sea buckthorn oil ceramide has better tissue healing ability. The healing rate of the solvent control group after 24 hours was 21.35%, and the healing rate of sea buckthorn oil ceramide after 24 hours was 59.48%. The compound of the present invention significantly improves the cell healing rate and has good skin tissue repair activity.

实施例5Example 5

弹性蛋白酶抑制实验测试抗衰老作用Elastase inhibition assay to test anti-aging effects

弹性蛋白酶抑制方法:取2mg/mL弹性蛋白酶溶液2mL,加入不同浓度样品(实施例1产物),充分涡旋混匀,在37℃、400r/min摇床振荡20min,立即加入pH6.0的0.5mol/L磷酸盐缓冲液5mL,涡旋混匀,取适量混匀液至2mL离心管内,在9 391×g下离心10min,精密吸取上清液200μL至96孔板内,在波长495nm处酶标仪测定吸光度,同时进行400~800nm光谱扫描。Elastase inhibition method: Take 2 mL of 2 mg/mL elastase solution, add samples of different concentrations (product of Example 1), vortex and mix thoroughly, shake on a shaker at 37°C, 400 r/min for 20 min, and immediately add 0.5 pH 6.0 5 mL of mol/L phosphate buffer, vortex to mix, take an appropriate amount of the mixed solution into a 2 mL centrifuge tube, centrifuge at 9 391 × g for 10 min, accurately pipette 200 μL of the supernatant into a 96-well plate, and enzyme at a wavelength of 495 nm Measure the absorbance with a standard instrument and perform a spectral scan from 400 to 800 nm at the same time.

以底物加酶溶液为空白对照组,底物加酶和样品溶液为酶抑制组,底物加样品不加酶溶液作扣背景用。每组均设3复孔。抑制率(%)=[1–(An–An′)/(A0–A0′)]×100%,式中,A0为加酶不加样品的吸光度,A0′为仅加底物不加样品和酶的吸光度,An为仅加样品溶液的吸光度,An′为加样品不加酶的吸光度。若An′>An,则表现为促进作用,促进率(%)=[1–(An′–An)/(A0–A0′)]×100%。The substrate plus enzyme solution was used as the blank control group, the substrate plus enzyme and sample solution was the enzyme inhibition group, and the substrate plus sample without enzyme solution was used to subtract the background. Each group is equipped with 3 multiple holes. Inhibition rate (%) = [1–(An–An′)/(A0–A0′)]×100%, in the formula, A0 is the absorbance of adding enzyme without adding sample, A0′ is adding only substrate without adding sample and the absorbance of the enzyme, An is the absorbance of the sample solution only, and An′ is the absorbance of the sample without enzyme. If An′>An, it shows a promotion effect, promotion rate (%) = [1–(An′–An)/(A0–A0′)]×100%.

结果如图2所示,沙棘油神经酰胺在不同浓度下对弹性蛋白酶均具有较好的抑制效果,具体而言,在0.25g/L的浓度时对弹性蛋白酶的抑制率为11.47%,在0.5g/L的浓度时对弹性蛋白酶的抑制率为23.93%,在1.0g/L的浓度时对弹性蛋白酶的抑制率为35.00%,在2.0g/L的浓度时对弹性蛋白酶的抑制率为50.00%。The results are shown in Figure 2. Sea buckthorn oil ceramide has a good inhibitory effect on elastase at different concentrations. Specifically, the inhibition rate of elastase at a concentration of 0.25g/L is 11.47%, and at a concentration of 0.5 The inhibition rate of elastase at the concentration of g/L is 23.93%, the inhibition rate of elastase at the concentration of 1.0g/L is 35.00%, and the inhibition rate of elastase at the concentration of 2.0g/L is 50.00 %.

按照相同的方法测试神经酰胺2对弹性蛋白酶的抑制活性,结果如图3所示,在浓度为0.25、0.5、1.0、2.0g/L时的弹性蛋白酶抑制率分别为10.12%、18.06%、28.84%和19.78%,其抑制效果不如相同浓度的沙棘油神经酰胺。The inhibitory activity of ceramide 2 on elastase was tested according to the same method. The results are shown in Figure 3. The elastase inhibition rates at concentrations of 0.25, 0.5, 1.0, and 2.0g/L were 10.12%, 18.06%, and 28.84 respectively. % and 19.78%, its inhibitory effect is not as good as the same concentration of sea buckthorn oil ceramide.

实施例6Example 6

MMP1又称间质性胶原酶、基质金属蛋白酶,属基质金属蛋白酶家族,其主要作用底物为纤维性胶原,可降解细胞外基质中的胶原纤维和明胶及改变细胞的微环境。MMP1在弹性蛋白中起着重要作用,抑制MMP1可提高成纤维细胞胶原蛋白和弹性蛋白合成,MMP活性降低可增加胶原合成速度。MMP1, also known as interstitial collagenase and matrix metalloproteinase, belongs to the matrix metalloproteinase family. Its main substrate is fibrillar collagen, which can degrade collagen fibers and gelatin in the extracellular matrix and change the microenvironment of cells. MMP1 plays an important role in elastin. Inhibiting MMP1 can increase collagen and elastin synthesis in fibroblasts, and reducing MMP activity can increase the rate of collagen synthesis.

将HaCaT细胞以1×105个/孔的密度种于96孔板,培养箱内过夜。24h后弃去上清液,加入含不同浓度的样品(实施例1产物)的培养基100μL,模型组不加入样品,阴性对照组为不含样品的DMEM培养基,每组3个复孔,在质量分数5% CO2、37℃环境中孵育2h后,辐射UVA或UVB紫外线。紫外线辐射光源与细胞之间的距离为15cm,UVA强度为200mJ/cm2,辐射时间为2h,UVB强度为50mJ/cm2,辐射时间为1h。结束辐射后,在培养箱内继续孵育12h。使用MMP-1ELISA试剂盒检测细胞内MMP-1基因表达。抑制率=1-(实验组MMP1表达量/模型组MMP1表达量)×100%。HaCaT cells were seeded in a 96-well plate at a density of 1×10 5 cells/well and kept in an incubator overnight. After 24 hours, the supernatant was discarded, and 100 μL of culture medium containing samples (products of Example 1) of different concentrations was added. No samples were added to the model group. The negative control group was DMEM culture medium without samples. Each group had 3 duplicate wells. After incubating for 2 hours in a mass fraction of 5% CO 2 and 37°C environment, UVA or UVB ultraviolet rays were irradiated. The distance between the ultraviolet radiation source and the cells is 15cm, the UVA intensity is 200mJ/cm 2 and the radiation time is 2h, the UVB intensity is 50mJ/cm 2 and the radiation time is 1h. After irradiation, continue incubation in the incubator for 12 hours. MMP-1 ELISA kit was used to detect intracellular MMP-1 gene expression. Inhibition rate = 1-(Expression amount of MMP1 in the experimental group/Expression amount of MMP1 in the model group) × 100%.

结果如图4、5所示,对于UVA,阴性对照组的MMP1表达量设为1,模型组的表达量为1.90,沙棘油神经酰胺在125、250、400mg/L的浓度时,相对模型组MMP1表达的抑制率为31%、46%、56%;对于UVB,阴性对照组的MMP1表达量设为1,模型组的表达量为2.33,沙棘油神经酰胺在125、250、400mg/L的浓度时,相对模型组MMP1表达的抑制率为35%、51%、69%。The results are shown in Figures 4 and 5. For UVA, the expression level of MMP1 in the negative control group was set to 1, and the expression level in the model group was 1.90. When sea buckthorn oil ceramide was at concentrations of 125, 250, and 400 mg/L, relative to the model group The inhibition rates of MMP1 expression were 31%, 46%, and 56%; for UVB, the MMP1 expression level in the negative control group was set to 1, the expression level in the model group was 2.33, and sea buckthorn oil ceramide was at 125, 250, and 400 mg/L. At different concentrations, the inhibition rates of MMP1 expression relative to the model group were 35%, 51%, and 69%.

UVA紫外线辐射后,角质形成细胞促进成纤维细胞MMP1表达升高,从而引起皮肤细胞外基质和皮肤胶原降解,导致皮肤光老化。上述结果表明,沙棘油神经酰胺可以抑制紫外线辐射导致的成纤维细胞产生MMP1,对防止皮肤光老化有一定作用。After UVA ultraviolet radiation, keratinocytes promote the increase of MMP1 expression in fibroblasts, which causes the degradation of skin extracellular matrix and skin collagen, leading to skin photoaging. The above results show that sea buckthorn oil ceramide can inhibit the production of MMP1 by fibroblasts caused by ultraviolet radiation, and has a certain effect on preventing skin photoaging.

实施例7Example 7

DPPH自由基清除检测抗氧化性能DPPH free radical scavenging test for antioxidant properties

DPPH是1,1-二苯-2-三硝苯肼,可以用于抗氧化实验。DPPH is 1,1-diphenyl-2-trinitophenylhydrazine, which can be used in antioxidant experiments.

将对应浓度(50、100、200、400、800mg/L)样品(实施例1产物)分别与0.1mol/LDPPH、无水乙醇溶液按1:1的体积比例混合均匀,DPPH与无水乙醇1:1等体积混合,室温避光反应30min,于517nm处测吸光值。样品与DPPH反应液的吸光度记作A1,样品与无水乙醇反应液的吸光度记作A2,DPPH与无水乙醇反应液的吸光度记作A3,样品的DPPH清除率=[1-(A1-A2)/A3]×100%。Mix the corresponding concentration (50, 100, 200, 400, 800mg/L) samples (product of Example 1) with 0.1mol/LDPPH and absolute ethanol solutions in a volume ratio of 1:1. DPPH and absolute ethanol are 1:1. : 1 Mix equal volumes, react at room temperature for 30 minutes in the dark, and measure the absorbance value at 517nm. The absorbance of the reaction solution between the sample and DPPH is recorded as A1, the absorbance of the reaction solution between the sample and absolute ethanol is recorded as A2, the absorbance of the reaction solution between DPPH and absolute ethanol is recorded as A3, and the DPPH clearance rate of the sample = [1-(A1-A2 )/A3]×100%.

结果如图6所示,在浓度为50、100、200、400、800mg/L时的DPPH自由基清除率分别为26.76%、34.38%、40.77%、51.72%、54.44%,表现出优异的抗氧化效果。按照相同的方法测试神经酰胺3B(即油酸神经酰胺)的抗氧化效果,结果如图7所示,在浓度为50、100、200、400、800mg/L时的DPPH自由基清除率为7.76%、12.82%、24.10%、29.60%、33.16%。沙棘油神经酰胺对DPPH的清除率高于神经酰胺3B,具有更好的抗氧化效果。The results are shown in Figure 6. The DPPH free radical scavenging rates at concentrations of 50, 100, 200, 400, and 800 mg/L were 26.76%, 34.38%, 40.77%, 51.72%, and 54.44% respectively, showing excellent anti- Oxidation effect. The antioxidant effect of ceramide 3B (oleic acid ceramide) was tested according to the same method. The results are shown in Figure 7. The DPPH free radical scavenging rate at concentrations of 50, 100, 200, 400 and 800 mg/L was 7.76. %, 12.82%, 24.10%, 29.60%, 33.16%. Sea buckthorn oil ceramide has a higher clearance rate for DPPH than ceramide 3B and has a better antioxidant effect.

实施例8Example 8

美白活性测试Whitening Activity Test

取指数生长期B16细胞,用质量分数0.25%胰蛋白酶-EDTA消化并吹打均匀,将细胞按3×105个/孔的密度接种于12孔板。于37℃、质量分数5%CO2环境中培养过夜。弃去上清液,加入含不同质量浓度样品(实施例1产物)的培养液,以不加样品的RPMI-1640培养基孵育为空白组,加DMEM培养基孵育为造模组,每组3个复孔,在质量分数5%CO2、37℃环境中孵育24h。将孔板中培养基弃去,用磷酸盐缓冲液(PBS)清洗一到两次后,加入1mL含质量分数10%DMSO的NaOH溶液(1mol/L)裂解细胞,置于80℃或100℃下恒温2h至细胞完全溶解。置于酶标仪中,于405nm下测吸光值。计算出黑色素抑制率=1-(各孔OD值/模型组OD值)×100%。Take B16 cells in the exponential growth phase, digest them with 0.25% trypsin-EDTA and pipet evenly, and seed the cells in a 12-well plate at a density of 3×10 5 cells/well. Cultivate overnight at 37°C and 5% CO2 . Discard the supernatant, add culture medium containing samples of different mass concentrations (products of Example 1), incubate with RPMI-1640 culture medium without adding samples as the blank group, add DMEM culture medium and incubate as the modeling group, each group has 3 Multiple wells were incubated for 24 h in a mass fraction of 5% CO 2 and 37°C environment. Discard the culture medium in the well plate, wash it once or twice with phosphate buffer saline (PBS), add 1 mL of NaOH solution (1 mol/L) containing 10% DMSO to lyse the cells, and place it at 80°C or 100°C. Keep at constant temperature for 2 hours until the cells are completely dissolved. Place it in a microplate reader and measure the absorbance value at 405nm. Calculate the melanin inhibition rate=1-(OD value of each well/OD value of model group)×100%.

结果如图8所示,空白对照组的黑色素含量设为1,造模组的黑色素表达为1.54,在浓度为10、20、40、80、100mg/L时,沙棘油神经酰胺的黑色素抑制率分别为15.10%、21.55%、24.98%、35.20%、46.59%,表现出很好的美白效果。The results are shown in Figure 8. The melanin content of the blank control group was set to 1, and the melanin expression of the model group was 1.54. When the concentrations were 10, 20, 40, 80, and 100 mg/L, the melanin inhibition rate of sea buckthorn oil ceramide was They are 15.10%, 21.55%, 24.98%, 35.20%, and 46.59% respectively, showing a good whitening effect.

以上所述,仅为本发明的具体实施方式,但本发明的保护范围并不局限于此,任何属于本技术领域的技术人员在本发明揭露的技术范围内,可轻易想到的变化或替换,都应涵盖在本发明的保护范围之内。因此,本发明的保护范围应该以权利要求的保护范围为准。The above are only specific embodiments of the present invention, but the protection scope of the present invention is not limited thereto. Any person skilled in the art can easily think of changes or substitutions within the technical scope disclosed in the present invention. All are covered by the protection scope of the present invention. Therefore, the protection scope of the present invention should be subject to the protection scope of the claims.

Claims (10)

1.沙棘油神经酰胺,其由沙棘油脂肪酸与鞘氨醇类化合物反应得到,所述鞘氨醇类化合物选自鞘氨醇、植物鞘氨醇、二氢鞘氨醇。1. Sea buckthorn oil ceramide is obtained by reacting sea buckthorn oil fatty acids with sphingosine compounds, and the sphingosine compounds are selected from the group consisting of sphingosine, phytosphingosine, and dihydrosphingosine. 2.根据权利要求1所述的沙棘油神经酰胺,其特征在于,所述沙棘油脂肪酸由沙棘籽油或沙棘果油水解得到。2. Seabuckthorn oil ceramide according to claim 1, characterized in that the seabuckthorn oil fatty acid is obtained by hydrolysis of seabuckthorn seed oil or seabuckthorn fruit oil. 3.根据权利要求1或2所述的沙棘油神经酰胺,其特征在于,所述沙棘油脂肪酸含有20~35wt%油酸、8~30wt%棕榈酸、4~40wt%亚油酸、2~30wt%亚麻酸、0.5~35wt%棕榈一烯酸、0.5~3wt%硬脂酸。3. The sea buckthorn oil ceramide according to claim 1 or 2, characterized in that the sea buckthorn oil fatty acid contains 20 to 35 wt% oleic acid, 8 to 30 wt% palmitic acid, 4 to 40 wt% linoleic acid, 2 to 30wt% linolenic acid, 0.5-35wt% palmitic acid, 0.5-3wt% stearic acid. 4.沙棘油神经酰胺,其组成包括:油酸神经酰胺,棕榈酸神经酰胺,亚油酸神经酰胺,亚麻酸神经酰胺,棕榈一烯酸神经酰胺,硬脂酸神经酰胺。4. Sea buckthorn oil ceramide, its composition includes: oleic acid ceramide, palmitic acid ceramide, linoleic acid ceramide, linolenic acid ceramide, palmitic acid ceramide, stearic acid ceramide. 5.根据权利要求4所述的沙棘油神经酰胺,其组成包括:20~35wt%油酸神经酰胺,8~30wt%棕榈酸神经酰胺,4~40wt%亚油酸神经酰胺,2~30wt%亚麻酸神经酰胺,0.5~35wt%棕榈一烯酸神经酰胺,0.5~3wt%硬脂酸神经酰胺。5. Seabuckthorn oil ceramide according to claim 4, its composition includes: 20-35wt% oleic acid ceramide, 8-30wt% palmitic acid ceramide, 4-40wt% linoleic acid ceramide, 2-30wt% Linolenic acid ceramide, 0.5~35wt% palmitoneic acid ceramide, 0.5~3wt% stearic acid ceramide. 6.根据权利要求4或5所述的沙棘油神经酰胺,其组成还包括:0~1wt%肉豆蔻酸神经酰胺。6. The sea buckthorn oil ceramide according to claim 4 or 5, further comprising: 0 to 1 wt% myristate ceramide. 7.权利要求1~6任意一项所述的沙棘油神经酰胺的合成方法,包括以下步骤:7. The synthesis method of sea buckthorn oil ceramide according to any one of claims 1 to 6, comprising the following steps: 在缩合剂、有机碱条件下,沙棘油脂肪酸与鞘氨醇类化合物反应,所述缩合剂为EDCI,所述有机碱为Et3N;Under the conditions of a condensing agent and an organic base, sea buckthorn oil fatty acids react with sphingosine compounds, the condensing agent is EDCI, and the organic base is Et 3 N; 所述沙棘油脂肪酸、鞘氨醇类化合物、EDCI、Et3N的摩尔比为1:(1~1.5):(1~2):(1~2),所述反应的溶剂为二氯甲烷、四氢呋喃、乙酸乙酯、乙腈中的至少一种。The molar ratio of the sea buckthorn oil fatty acid, sphingosine compounds, EDCI, and Et 3 N is 1: (1~1.5): (1~2): (1~2), and the solvent of the reaction is dichloromethane , at least one of tetrahydrofuran, ethyl acetate, and acetonitrile. 8.权利要求1~6任意一项所述的沙棘油神经酰胺在化妆品、药品、膳食品或保健品中的用途。8. Use of the sea buckthorn oil ceramide according to any one of claims 1 to 6 in cosmetics, medicines, dietary products or health care products. 9.根据权利要求8所述的用途,其特征在于,所述沙棘油神经酰胺具有皮肤屏障修复、组织愈合、抗衰老、抗光老化、抗氧化、促进胶原合成、维持弹性蛋白活力、美白功效中的至少一种。9. The use according to claim 8, characterized in that the sea buckthorn oil ceramide has skin barrier repair, tissue healing, anti-aging, anti-photoaging, anti-oxidation, promoting collagen synthesis, maintaining elastin vitality, and whitening effects. at least one of them. 10.一种组合物,包括权利要求1~6任意一项所述的沙棘油神经酰胺,所述组合物具有皮肤屏障修复、组织愈合、抗衰老、抗光老化、抗氧化、促进胶原合成、维持弹性蛋白活力、美白功效中的至少一种。10. A composition, comprising the sea buckthorn oil ceramide according to any one of claims 1 to 6, said composition having skin barrier repair, tissue healing, anti-aging, anti-photoaging, anti-oxidation, promoting collagen synthesis, Maintain at least one of elastin vitality and whitening effects.
CN202310051531.2A 2022-11-25 2023-02-02 Sea buckthorn oil ceramide and its synthesis method and use Pending CN117304057A (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
CN202310051531.2A CN117304057A (en) 2023-02-02 2023-02-02 Sea buckthorn oil ceramide and its synthesis method and use
EP23893956.5A EP4624449A1 (en) 2022-11-25 2023-11-23 Vegetable oil ceramides, synthesis method therefor, and use thereof
PCT/CN2023/133524 WO2024109867A1 (en) 2022-11-25 2023-11-23 Vegetable oil ceramides, synthesis method therefor, and use thereof
KR1020257019053A KR20250112263A (en) 2022-11-25 2023-11-23 Plant oil ceramides and their synthesis methods and uses
JP2025529875A JP2025536776A (en) 2022-11-25 2023-11-23 Vegetable oil ceramide and its synthesis method and use
AU2023383894A AU2023383894A1 (en) 2022-11-25 2023-11-23 Vegetable oil ceramides, synthesis method therefor, and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202310051531.2A CN117304057A (en) 2023-02-02 2023-02-02 Sea buckthorn oil ceramide and its synthesis method and use

Publications (1)

Publication Number Publication Date
CN117304057A true CN117304057A (en) 2023-12-29

Family

ID=89261043

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202310051531.2A Pending CN117304057A (en) 2022-11-25 2023-02-02 Sea buckthorn oil ceramide and its synthesis method and use

Country Status (1)

Country Link
CN (1) CN117304057A (en)

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006020506A (en) * 2004-07-06 2006-01-26 Ichimaru Pharcos Co Ltd Water-soluble ceramide-formulated food and drink
JP2006022005A (en) * 2004-07-06 2006-01-26 Ichimaru Pharcos Co Ltd Method for producing plant-derived ceramide
US20110065801A1 (en) * 2008-06-13 2011-03-17 Evonik Goldschmidt Gmbh Enzymatic synthesis of sphingolipids
US20110251378A1 (en) * 2007-04-09 2011-10-13 The Regents Of The University Of California One-pot synthesis of alpha/beta-o-glycolipids
CN105732412A (en) * 2016-03-10 2016-07-06 陕西中医药大学 Amide compound for treating stroke and preparation method thereof
KR20170084950A (en) * 2016-01-13 2017-07-21 주식회사 엘씨에스바이오텍 Green-ceramides, compositions comprising the green-ceramides and method for preparing the green-ceramides
US20190300917A1 (en) * 2018-03-29 2019-10-03 Evonik Degussa Gmbh Process for preparing sphingolipids
KR20220037703A (en) * 2020-09-18 2022-03-25 주식회사 엘씨에스바이오텍 Water dispersion composition comprising complex ceramide

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006020506A (en) * 2004-07-06 2006-01-26 Ichimaru Pharcos Co Ltd Water-soluble ceramide-formulated food and drink
JP2006022005A (en) * 2004-07-06 2006-01-26 Ichimaru Pharcos Co Ltd Method for producing plant-derived ceramide
US20110251378A1 (en) * 2007-04-09 2011-10-13 The Regents Of The University Of California One-pot synthesis of alpha/beta-o-glycolipids
US20110065801A1 (en) * 2008-06-13 2011-03-17 Evonik Goldschmidt Gmbh Enzymatic synthesis of sphingolipids
KR20170084950A (en) * 2016-01-13 2017-07-21 주식회사 엘씨에스바이오텍 Green-ceramides, compositions comprising the green-ceramides and method for preparing the green-ceramides
CN105732412A (en) * 2016-03-10 2016-07-06 陕西中医药大学 Amide compound for treating stroke and preparation method thereof
US20190300917A1 (en) * 2018-03-29 2019-10-03 Evonik Degussa Gmbh Process for preparing sphingolipids
KR20220037703A (en) * 2020-09-18 2022-03-25 주식회사 엘씨에스바이오텍 Water dispersion composition comprising complex ceramide

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
HYUN KYUNG CHOI ETAL,: "Ceramide NPs derived from natural oils of Korean traditional plants enhance skin barrier functions and stimulate expressions of genes for epidermal homeostasis", 《J COSMET DERMATOL.》, 31 December 2022 (2022-12-31), pages 1 *
LEONA: "神经酰胺肌肤年轻 的秘密", 《中国化妆品》, 31 December 2019 (2019-12-31), pages 75 - 77 *
MYOUNG JIN OH ETAL: "Novel phytoceramides containing fatty acids of diverse chain lengths are better than a single C18-ceramide N-stearoyl phytosphingosine to improve the physiological properties of human stratum corneum", 《CLINICAL, COSMETIC AND INVESTIGATIONAL DERMATOLOGY》, 31 December 2017 (2017-12-31), pages 364 *
李医明: "《中药化学》", 31 December 2018, pages: 359 - 360 *
王洪新: "《 食品新资源》", 31 December 2002, pages: 244 - 245 *
高兴华: "《皮肤性病学》", 31 December 2007, pages: 97 *

Similar Documents

Publication Publication Date Title
JP5346339B2 (en) Wrinkle improving and moisturizing composition and cosmetics
CN115894279A (en) Olive oil ceramide and synthesis method and application thereof
CN116023289A (en) Avocado oil ceramide and synthesis method and application thereof
KR20130010904A (en) Preparation created from an in vitro culture of dedifferentiated, non-elicited cells of the argania tree, use thereof for treating skin ageing, inflammation and scarring, and production thereof
US20180000722A1 (en) Preparation for protecting against extrinsic and intrinsic skin aging
CN116023288A (en) Grape seed oil ceramide and synthesis method and application thereof
CN116041206A (en) Safflower seed oil ceramide and its synthesis method and use
JP4939766B2 (en) Basement membrane stabilizer
CN115974714A (en) Shea butter ceramide, and its synthesis method and use
CN115974715A (en) Peony seed oil ceramide, and synthesis method and application thereof
WO2024109867A1 (en) Vegetable oil ceramides, synthesis method therefor, and use thereof
CN117402074A (en) Hemp seed oil ceramide and its synthesis method and use
CN117285432A (en) Linseed oil ceramide and synthesis method and application thereof
CN117304060A (en) Soybean oil ceramide and its synthesis method and use
CN116041205A (en) Borage oil ceramide and its synthesis method and application
CN116003286A (en) Green thorn fruit oil ceramide and its synthesis method and application
CN116003287A (en) Sunflower seed oil ceramide and synthesis method and application thereof
CN117304057A (en) Sea buckthorn oil ceramide and its synthesis method and use
CN116003288A (en) Nanmei oleo ceramide and its synthesis method and use
CN115974716A (en) Cottonseed oil ceramide and synthesis method and application thereof
CN116003289A (en) Watermelon seed oil ceramide and synthesis method and application thereof
CN117304061A (en) Yuanbao maple seed oil ceramide and its synthesis method and use
CN117304058A (en) Walnut oil ceramide and its synthesis method and use
CN117285434A (en) Monkey bread seed oil ceramide and synthesis method and application thereof
CN117304063A (en) Arglycerylceramide and its synthesis method and use

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination